The combination of these mutations with established HCC serum markers, specifically AFP, AFP-L3 and PIVKA-II, resulted in excellent accuracy (AUROC: 0.87) with improved sensitivity and specificity for early HCC diagnosis [54]. Here, AFP is linked to hepatocellular carcinoma.